Novo Nordisk A/S (NVO)

Last Price: 101.41 (2021-09-17)

Company Description

Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $19.45B
Net Income (Most Recent Fiscal Year) $6.46B
PE Ratio (Current Year Earnings Estimate) 31.52
PE Ratio (Trailing 12 Months) 33.14
PEG Ratio (Long Term Growth Estimate) 2.87
Price to Sales Ratio (Trailing 12 Months) 11.46
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 22.47
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 32.55
Pre-Tax Margin (Trailing 12 Months) 42.91%
Net Margin (Trailing 12 Months) 34.17%
Return on Equity (Trailing 12 Months) 72.72%
Return on Assets (Trailing 12 Months) 30.72%
Current Ratio (Most Recent Fiscal Quarter) 1.06
Quick Ratio (Most Recent Fiscal Quarter) 0.80
Debt to Common Equity (Most Recent Fiscal Quarter) 0.19
Inventory Turnover (Trailing 12 Months) 1.21
Book Value per Share (Most Recent Fiscal Quarter) $4.12
Earnings per Share (Most Recent Fiscal Quarter) $0.85
Earnings per Share (Most Recent Fiscal Year) $2.76
Diluted Earnings per Share (Trailing 12 Months) $3.06
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 2.35B
Free Float 2.35B
Market Capitalization $238.80B
Average Volume (Last 20 Days) 1.04M
Beta (Past 60 Months) 0.41
Percentage Held By Insiders (Latest Annual Proxy Report) 0.07%
Percentage Held By Institutions (Latest 13F Reports) 5.58%
Annual Dividend (Based on Last Quarter) $0.77
Dividend Yield (Based on Last Quarter) 0.76%